A collaboration led by CMS and America’s Health Insurance Plans released 7 core sets of quality measures created to reduce complexity, decrease cost burden, and ensure high-quality care.
A collaboration led by CMS and America’s Health Insurance Plans (AHIP) has resulted in 7 sets of core quality measures created to support quality improvement and provide better alignment.
The measures were developed as part of a broad Core Quality Measures Collaborative of healthcare system participants in an effort to establish measures that will reduce complexity for reporting clinicians, decrease cost burden to consumers and the system, and ensure high-quality care for patients.
“In the U.S. health care system, where we are moving to measure and pay for quality, patients and care providers deserve a uniform approach to measure quality,” CMS Acting Administrator Andy Slavitt said in a statement. “This agreement today will reduce unnecessary burden for physicians and accelerate the country's movement to better quality.”
The core measures released are in the following 7 sets:
The measures will be implemented in several stages. While CMS is already using measures from the core sets, it will implement new core measures while eliminating redundant measures. The Health Care Payment Learning and Action Network will integrate the measures as well. Finally, when contracts come up for renewal, commercial health plans will implement these core sets of measures.
Helen Burstin, MD, MPH, chief scientific officer of the National Quality Forum (NQF), which also participated in the Collaborative’s efforts, called the agreement on core measures sets “an important step” toward making healthcare more effective and efficient.
“Clinicians need fewer and more meaningful measures that reduce the burden of reporting multiple quality measures to different entities and take time away from direct patient care,” she said. “And consumers need measures that provide actionable information to better inform healthcare decisions.”
NQF provided technical assistance and many of the core measures are already endorsed by the organization.
The core measure sets will be reviewed on an ongoing basis and the Collaborative will develop a process to ensure the measure sets reflect the most up-to-date evidence.
“The Collaborative's efforts are a critical step forward in improving health outcomes and quality care for patients,” Carmella Bocchino, executive vice president of AHIP, said in a statement. “This process will ensure measures and reporting are consistent across programs in both the private and public sectors.”
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More